Evidence map›Paper›PMID 28403074›Full record

ArticleMedicine2017

Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.

Hang Su, Jie Zhang, Wenwei Ren, Ying Xie, Jingyan Tao, Xiangyang Zhang, Jincai He

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Specific Glutamatergic Projection to Claustrum for Regulating Methamphetamine Abstinence Anxiety-Like Behaviors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Distinct eLPBTheranostics · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Intraperitoneal injection of buprenorphine on anxiety-like behavior and alteration in expression ofVeterinary research forum : an international quarterly journal · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hang SuDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai Department of Neurology, The First Affiliated Hospital of Yangtze University, Jingzhou Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou Beijing HuiLongGuan Hospital, Peking University, Beijing, China Department of Psychiatry and Behavioral Sciences, Harris County Psychiatric Center, The University of Texas Health Science Center at Houston, Houston, TX.
Jie Zhang
Wenwei Ren
Ying Xie
Jingyan Tao
Xiangyang Zhang
Jincai He
Beijing HuiLongGuan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety is often a core element of withdrawal symptoms; however, risk factors associated with anxiety symptoms during the early stage of withdrawal in methamphetamine (METH) users are not well understood. Two hundred ten METH-dependent subjects who had been abstinent for 1 to 7 days were recruited. We used a set of self-administrative questionnaires eliciting information on sociodemographics, detailed drug use history and anxiety. Beck Anxiety Inventory (BAI) was used to measure anxiety symptoms. METH users had a mean BAI score of 6.9; 72 (34.3%) of the study sample had anxiety symptoms during acute METH withdrawal, including 42 (20.0%) with mild anxiety, 25 (11.9%) with moderate anxiety, and 5 (2.4%) with severe anxiety. In addition, gender (female), higher frequency of drug use, and history of polysubstance use were significantly correlated with anxiety symptoms during acute METH withdrawal. Anxiety symptoms appear to be common during the first week of METH abstinence, and several risk factors are identified.

Indexed as

AdolescentAdultAmphetamine-Related DisordersAnxietyCentral Nervous System StimulantsFemaleHumansMaleMethamphetamineMiddle AgedPsychiatric Status Rating ScalesRisk FactorsSex FactorsSubstance Withdrawal SyndromeSurveys and QuestionnairesTime FactorsCentral Nervous System StimulantsMethamphetamine

Identifiers

PMID28403074
PMCPMC5403071
OpenAlexW2607062688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.